Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Guanglei Fu; Wei Liu; Shanshan Feng; Xiuli Yue

doi:10.1039/c2cc36456e

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Guanglei Fu
, Wei Liu
, Shanshan Feng
, Xiuli Yue^*

^*Corresponding author for this work

School of Life Science and Technology, Harbin Institute of Technology

Research output: Contribution to journal › Article › peer-review

349 Scopus citations

Abstract

Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

Original language	English
Pages (from-to)	11567-11569
Number of pages	3
Journal	Chemical Communications
Volume	48
Issue number	94
DOIs	https://doi.org/10.1039/c2cc36456e
State	Published - 31 Oct 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1039/c2cc36456e

Cite this

@article{d96a4b337cac496e8713e3b4f3b40ccc,

title = "Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy",

abstract = "Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.",

author = "Guanglei Fu and Wei Liu and Shanshan Feng and Xiuli Yue",

year = "2012",

month = oct,

day = "31",

doi = "10.1039/c2cc36456e",

language = "英语",

volume = "48",

pages = "11567--11569",

journal = "Chemical Communications",

issn = "1359-7345",

publisher = "Royal Society of Chemistry",

number = "94",

}

TY - JOUR

T1 - Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

AU - Fu, Guanglei

AU - Liu, Wei

AU - Feng, Shanshan

AU - Yue, Xiuli

PY - 2012/10/31

Y1 - 2012/10/31

N2 - Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

AB - Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

UR - https://www.scopus.com/pages/publications/84868382878

U2 - 10.1039/c2cc36456e

DO - 10.1039/c2cc36456e

M3 - 文章

C2 - 23090583

AN - SCOPUS:84868382878

SN - 1359-7345

VL - 48

SP - 11567

EP - 11569

JO - Chemical Communications

JF - Chemical Communications

IS - 94

ER -

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this